![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18611-18618, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Azidothymidine (AZT) is a widely used inhibitor
of type 1 human immunodeficiency virus reverse transcriptase
(RT) that acts as chain terminator. Upon treatment, mutations
conferring AZT resistance to RT are gradually selected. It has been
shown that resistant RT is able to unblock the AZT-terminated primer by
an ATP-dependent mechanism. However, this resistance
mechanism has only been demonstrated for DNA-dependent DNA
elongation. Here, we compared the AZT resistance of mutant RT during
DNA elongation on DNA and RNA templates. We showed that, during DNA
elongation, primer unblocking and rescue of DNA synthesis take place
with similar rate constants on DNA and RNA templates. However, the fraction of a primer eventually repaired during
RNA-dependent DNA synthesis is 2× lower compared with that
of DNA-dependent synthesis, leading to reduced resistance.
We also compared the initiation of reverse transcription, which uses
tRNA
Primer Unblocking and Rescue of DNA Synthesis by Azidothymidine
(AZT)-resistant HIV-1 Reverse Transcriptase
COMPARISON BETWEEN INITIATION AND ELONGATION OF REVERSE
TRANSCRIPTION AND BETWEEN (
) AND (+) STRAND DNA SYNTHESIS*
,
,
, and
Unité Propre de Recherche
9002 du CNRS, Institut de Biologie Moléculaire et Cellulaire,
15 rue René Descartes, 67084 Strasbourg cedex, France and the
§ Jewish General Hospital, Lady Davis Institute for
Medical Research, Montréal, Quebec H3T 1E2, Canada

) DNA strand synthesis. Our results demonstrate that
the efficiency of primer unblocking conferred by the AZT resistance
mutations greatly vary during the different steps of the provirus
synthesis. These results also suggest that inhibitors specifically targeting the initiation of reverse transcription might
prove to be advantageous, as compared with elongation
inhibitors.
*
This work was supported by the Agence Nationale de
Recherches sur le SIDA, a Biomed II grant from the European Union, and a "Jeunes Equipes" grant from the CNRS (to R. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
33-3-88-41-70-91; Fax: 33-3-88-60-22-18; E-mail: r.marquet@ibmc.u-
strasbg.fr.
This article has been cited by other articles:
![]() |
L. Odriozola, C. Cruchaga, M. Andreola, V. Dolle, C. H. Nguyen, L. Tarrago-Litvak, A. Perez-Mediavilla, and J. J. Martinez-Irujo Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase Inhibit Phosphorolysis and Resensitize the 3'-Azido-3'-deoxythymidine (AZT)-resistant Polymerase to AZT-5'-triphosphate J. Biol. Chem., October 24, 2003; 278(43): 42710 - 42716. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Marchand and M. Gotte Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase: IMPLICATIONS FOR POLYMERASE TRANSLOCATION AND DRUG RESISTANCE J. Biol. Chem., September 12, 2003; 278(37): 35362 - 35372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |